Eliminating the Three Evil E's in Study Startup

A paradigm shift in starting clinical trials

In an effort to confront the oft-mentioned costs of drug development, the clinical trials industry has been evolving from its slow paper-based methods and standalone spreadsheets towards automated, cloud-based systems. There has always been a strong focus on study conduct and quality. But as stakeholders are increasingly aware that better study startup (SSU) processes are linked to shorter clinical timelines, the emphasis is shifting in that direction. A paradigm shift is needed in order to eliminate the three evil "e's" — email, Excel, and e-meetings — long associated with starting clinical trials, with the potential to ultimately reduce timelines and improve data quality. The webinar with focus on addressing the inefficiencies associated with the three evil "e's".

In this webinar we will explore:

  • Improving operational performance with intelligent document routing and milestone planning
  • Ensuring regulatory/SOP compliance (e.g., Clinical Trial Regulation EU No. 536/2014)
  • Continuity of service with role management and alerts
  • Empowering risk management with real-time reporting

This webinar is applicable to:

  • Sponsor and CRO roles responsible for site selection and activation
  • Sponsor and CRO roles responsible for collecting and evaluating trial metrics


Jaime is a clinical trial and innovative product strategist, experienced in building, evolving and implementing market-leading technology solutions for many of the world's leading pharmaceutical, biotech, research and medical device organizations. Her passion is transforming study management and trial execution processes through the creation of optimized business processes, which are supported by facilitating systems – allowing sponsor and investigator teams to meet their patient and clinical program goals faster and more efficiently.
Director, Product Management
Jaime Lau
Barry Milton
Barry is a clinical trial and operations management expert. His experiences as an Oncology nurse, clinical trial coordinator and his senior management roles at Novartis, Roche, Merck, and AstraZeneca provides him with a well-rounded set of skills and experiences in the clinical trial space.
Head of Business Operations

Need more information?

Contact us with your questions.